As a follow on from this related McBlawg post, a number of media outlets/bloggers have reported on the latest development in this area over the last 24 hours.
Essentially, over the next year, the BBC will start to live-cast BBC1 and BBC2 via the web in the next step of their experimentation with releasing content other than on TV.
Here is the release from the BBC, Main BBC channels go live on net
"The live simulcast for both channels will be available from 27 November".
--
Some interesting and differing views about this already in the blogosphere, such as Got a Computer? You’ll Need To Buy a £139.50 Licence, BBC to transmit live, simulcast style, via iPlayer and BBC channels to start live streaming
Sure will be interesting to see how this pans out. I wonder what Glyn Moody makes of this? He responded here.
--
++UPDATE++
And here are the links to BBC ONE and BBC TWO live streaming.
blurb
Showing posts with label BBC. Show all posts
Showing posts with label BBC. Show all posts
Thursday, 20 November 2008
Wednesday, 10 September 2008
BBC FREE
Great full page article in today's (free) Metro newspaper entitled, "Web TV: The next generation". As far as I know, the article is not online.
The top of the page in question reads, "EXTRA-TERRESTRIAL VIEWING TELEVISION SCHEDULES WILL SOON BE A THING OF THE PAST, AS FIONA MACDONALD DISCOVERS
From the abstract:-
From Saturday, telly addicts will be able to experience a new on-demand service from the BBC: iPlayer is introducing 'Series Stacking', allowing us to catch up on every episode of selected shows. As the BBC's controller of Multiplatform, Simon Nelson, puts it: 'Now, you'll be able to join a series half way through, following a friend's recommendation, for example, and catch up on all the previous episodes - or watch them all in one go over a weekend.' But how does that fit in with BBC's remit? And with the onset of internet TV, will a new small screen be taking pride of place in our living rooms? In a brave new broadcasting world, we've produced a TV guide that might prove more handy than any schedules.
The BBC introduced their revolutionary iPlayer service about 8 months ago. Fantastic service I have to say. As matters stand, content is currently available for 7 days after broadcast.
From Saturday however, this changes big style. IMHO, this is a truly bold and significant move (in the right direction) by the BBC and other will surely follow. Over the years, I've made more connections with folks at the BBC than any other media corporation/company and news like this is most certainly "music" to McDawg's eyes/ears and that of millions of others.
Follows the opening para from Fiona MacDonald's excellent article:-
With digital taking over our viewing has gone extra-terrestrial. In the eight months since it fully launched, BBCi Player has proven a bigger hit than anticipated: according to the internet service provider PlusNet, streaming is now 168.9 per cent higher per day. 'In five years, it's likely people will watch content on their computer, whenever they want.' says PlusNet's Neil Armstrong. 'Traditional TV schedules will be thrown out of the window. '
snip..
iPlayer is expected to have 1 million daily users by Christmas, yet none of them need a TV licence if they watch material after it has been broadcast on TV.
The article also contains news of other cool developments to follow in the near future all of which are equally exciting.
Well done BBC !!!
The top of the page in question reads, "EXTRA-TERRESTRIAL VIEWING TELEVISION SCHEDULES WILL SOON BE A THING OF THE PAST, AS FIONA MACDONALD DISCOVERS
From the abstract:-
From Saturday, telly addicts will be able to experience a new on-demand service from the BBC: iPlayer is introducing 'Series Stacking', allowing us to catch up on every episode of selected shows. As the BBC's controller of Multiplatform, Simon Nelson, puts it: 'Now, you'll be able to join a series half way through, following a friend's recommendation, for example, and catch up on all the previous episodes - or watch them all in one go over a weekend.' But how does that fit in with BBC's remit? And with the onset of internet TV, will a new small screen be taking pride of place in our living rooms? In a brave new broadcasting world, we've produced a TV guide that might prove more handy than any schedules.
The BBC introduced their revolutionary iPlayer service about 8 months ago. Fantastic service I have to say. As matters stand, content is currently available for 7 days after broadcast.
From Saturday however, this changes big style. IMHO, this is a truly bold and significant move (in the right direction) by the BBC and other will surely follow. Over the years, I've made more connections with folks at the BBC than any other media corporation/company and news like this is most certainly "music" to McDawg's eyes/ears and that of millions of others.
Follows the opening para from Fiona MacDonald's excellent article:-
With digital taking over our viewing has gone extra-terrestrial. In the eight months since it fully launched, BBCi Player has proven a bigger hit than anticipated: according to the internet service provider PlusNet, streaming is now 168.9 per cent higher per day. 'In five years, it's likely people will watch content on their computer, whenever they want.' says PlusNet's Neil Armstrong. 'Traditional TV schedules will be thrown out of the window. '
snip..
iPlayer is expected to have 1 million daily users by Christmas, yet none of them need a TV licence if they watch material after it has been broadcast on TV.
The article also contains news of other cool developments to follow in the near future all of which are equally exciting.
Well done BBC !!!
Sunday, 3 August 2008
Open access to data in clinical medicine
A follow on from my last blog post about Multiple Sclerosis.
Yesterday, I was reading this post on Martin Fenner's blog Gobbledygook and left a short comment containing a link to a comment I had posted last year at PLoS Clinical Trials.
My comment over at PLoS was directly in relation to Liz Wager's 2006 Manuscript entitled Publishing Clinical Trial Results: The Future Beckons
When I re-read my PLoS comment, I wanted to spin back to this section:-
A few months ago (27th April), the BBC aired a real eye opener in the form of This World documentary "Drug trials outsourced to India". This can easily be found searching for "this world drug trials India". Even more recently, it was the BBC (again) who highlighted serious concerns about a MS trial "Concern over major MS drug trial". This can easily be found searching for "concern over major MS drug trial". Despite all of these issues, no-one seems to be concerned, and more worryingly, willing to do anything about this !!
I was alluding to two particular BBC documentaries about clinical trials.
When I originally submitted my comment to PLoS back in 2006, it wasn't possible to embed links.
The links are Drug trials outsourced to India and Concern over major MS drug trial
I repeat what I said, "Despite all of these issues, no-one seems to be concerned, and more worryingly, willing to do anything about this !!"
Now, let's spin back to Martin's post above:-
"This required reporting of results has so far largely gone unnoticed in the medical community, but will dramatically change the way research involving patients is conducted and reported. The 12 month deadline will probably lead to earlier reporting of many trial results, and not publishing negative results will be much more difficult. The required reporting in a standardized format will also facilitate the meta-analysis of several similar trials."
Now specifically in terms of Multiple Sclerosis (MS), to demonstrate the importance of what Martin is talking about, let's focus on that BBC report Concern over major MS drug trial
When I initially read it, I was quite literally stunned. So much so that it directly led to me writing to PLoS about my views.
As the BBC report says:-
"It is feared patients currently taking expensive drugs like beta interferon may be kept in the dark even after the ten year study is complete."
It appears that due to Pharma pressure, after 10 years research at a cost of £500,000,000 to UK taxpayers, all of this ultimately led to nothing.
Since I know him, I contacted Sir Iain Chalmers who aired his concerns to the BBC. In response, he said, "There’s a very nasty smell coming from the whole business, Graham."
As Martin flags up in the comments section of his post, and as I was already aware since I participated, the WHO recently carried out a Public Consultation entitled Reporting of Findings of Clinical Trials.
As such, taking all of this into consideration, the MANDATORY registration of data acquired from clinical trials to be made open is a very large step in the right direction. Moreover, with all of the mandates now bounding around for public access to such data/knowledge it certainly looks like, at last, we're moving out of the dark ages. About time too.
Yesterday, I was reading this post on Martin Fenner's blog Gobbledygook and left a short comment containing a link to a comment I had posted last year at PLoS Clinical Trials.
My comment over at PLoS was directly in relation to Liz Wager's 2006 Manuscript entitled Publishing Clinical Trial Results: The Future Beckons
When I re-read my PLoS comment, I wanted to spin back to this section:-
A few months ago (27th April), the BBC aired a real eye opener in the form of This World documentary "Drug trials outsourced to India". This can easily be found searching for "this world drug trials India". Even more recently, it was the BBC (again) who highlighted serious concerns about a MS trial "Concern over major MS drug trial". This can easily be found searching for "concern over major MS drug trial". Despite all of these issues, no-one seems to be concerned, and more worryingly, willing to do anything about this !!
I was alluding to two particular BBC documentaries about clinical trials.
When I originally submitted my comment to PLoS back in 2006, it wasn't possible to embed links.
The links are Drug trials outsourced to India and Concern over major MS drug trial
I repeat what I said, "Despite all of these issues, no-one seems to be concerned, and more worryingly, willing to do anything about this !!"
Now, let's spin back to Martin's post above:-
"This required reporting of results has so far largely gone unnoticed in the medical community, but will dramatically change the way research involving patients is conducted and reported. The 12 month deadline will probably lead to earlier reporting of many trial results, and not publishing negative results will be much more difficult. The required reporting in a standardized format will also facilitate the meta-analysis of several similar trials."
Now specifically in terms of Multiple Sclerosis (MS), to demonstrate the importance of what Martin is talking about, let's focus on that BBC report Concern over major MS drug trial
When I initially read it, I was quite literally stunned. So much so that it directly led to me writing to PLoS about my views.
As the BBC report says:-
"It is feared patients currently taking expensive drugs like beta interferon may be kept in the dark even after the ten year study is complete."
It appears that due to Pharma pressure, after 10 years research at a cost of £500,000,000 to UK taxpayers, all of this ultimately led to nothing.
Since I know him, I contacted Sir Iain Chalmers who aired his concerns to the BBC. In response, he said, "There’s a very nasty smell coming from the whole business, Graham."
As Martin flags up in the comments section of his post, and as I was already aware since I participated, the WHO recently carried out a Public Consultation entitled Reporting of Findings of Clinical Trials.
As such, taking all of this into consideration, the MANDATORY registration of data acquired from clinical trials to be made open is a very large step in the right direction. Moreover, with all of the mandates now bounding around for public access to such data/knowledge it certainly looks like, at last, we're moving out of the dark ages. About time too.
Sunday, 27 July 2008
BBC Scotland Investigates: 2008: Scotland's Hidden Epidemic: The Truth About Multiple Sclerosis
PRELUDE
A major donation from Harry Potter author JK Rowling will help combat Multiple Sclerosis (MS), a disease which affects one in 500 Scots. Funding for the £2.5m project will largely come from Multiple Sclerosis Society Scotland, which has been gifted a substantial sum from the author for this work.
Yesterday, my Mum mentioned a documentary on the BBC that she saw the other day that I missed.
Being a UK TV License Fee payer, I was able to watch it online here via the BBCi-player.
If you are able to access it, I urge you to watch this most compelling 30 minute programme.
Living life with multiple sclerosis by Elizabeth Quigley, BBC Scotland
Whilst I never met her, my Mum’s mum died at an early age due to MS. The documentary was therefore of particular interest to us and I would suspect, the ~ 10,500 MS patients in Scotland and beyond.
The documentary features an interview with author, JK Rowling. JKR apparently rarely speaks about the loss of her own mother at an early age (45) to MS but chose to do so here and also here.
Further reading:-
Research features in TV documentary
JK Rowling and the Multiple Sclerosis Society Scotland fund a new MS Research Centre
Sunday Herald article
Subscribe to:
Posts (Atom)
Posts
